Stimulation by vasopressin of ERK phosphorylation and vector-driven water flux in astrocytes is transactivation-dependent.
Stimulation by vasopressin of ERK phosphorylation and vector-driven water flux in astrocytes is transactivation-dependent.
复制标题
DOI:
10.1016/j.ejphar.2008.03.030
复制
发表时间:
2008-06
影响因子:
5
通讯作者:
Ting Du;D. Song;Hongmei Li;Baoman Li;Liping Cai;L. Hertz;Liang Peng
中科院分区:
文献类型:
--
作者:
Ting Du;D. Song;Hongmei Li;Baoman Li;Liping Cai;L. Hertz;Liang Peng
Vasopressin acts on astrocytic Gqprotein- and phospholipase C-coupled V1receptors. In mesangial cells, which also express the V1receptor, it stimulates cell growth by activating mitogen-activated protein kinase (MAP kinase) secondary to transactivation of the epidermal growth factor (EGF) receptor. Transactivation is an intracellular/extracellular process, in which activation of a Gqor a Gi/oprotein-coupled receptor leads to metalloproteinase-catalyzed shedding of an EGF receptor agonist, which stimulates EGF receptors on the same cell and/or its neighbor(s). The goal of the present study was to investigate if vasopressin signaling is mediated by transactivation also in astrocytes and whether such a transactivation is required for its ability to facilitate vector-driven water fluxes. Vasopressin concentrations between 10−12and 10−6M were found to lead to phosphorylation (activation) of extracellular regulated kinase 1 and 2 (ERK1/2). Phosphorylation of ERK1/2could be completely inhibited by either AG1478, an inhibitor of the EGF receptor-activated tyrosine kinase, or GM6001, an inhibitor of Zn2+-activated metalloproteinases, indicating the involvement of transactivation. Exposure to a hypotonic medium caused an immediate (within one min) increase in cell water volume (demonstrated by decrease of fluorescence quenching of calcein), part of which was dependent upon the presence of vasopressin, added at a concentration of 1×10−8M. This vasopressin-dependent component persisted throughout the duration of the experiment (22 min). The effect of vasopressin was abolished in the presence of AG1478, indicating its dependence upon transactivation, and by U0126 an inhibitor of the MAP kinase/ERK kinase (MEK), and thus of ERK1/2phosphorylation.